Neuroleptic malignant syndrome: Difference between revisions
Ttenbergen (talk | contribs) m 1 revision imported |
Ttenbergen (talk | contribs) m adding {{Data Integrity Check List}} |
||
| (14 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
{{ICD10 transition status | {{ICD10 transition status | ||
| OldDxArticle =Malignant Neuroleptic Syndrome| CurrentStatus = | | OldDxArticle =Malignant Neuroleptic Syndrome| | ||
CurrentStatus = reconciled | |||
| InitialEditorAssigned = Joyce Peterson | | InitialEditorAssigned = Joyce Peterson | ||
}} | }} | ||
{{ICD10 dx | {{ICD10 dx | ||
| MinimumCombinedCodes = | |||
| ICD10 Code=G21.0 | | ICD10 Code=G21.0 | ||
| BugRequired= | | BugRequired= | ||
}} | }} | ||
{{ICD10 category|Neuro}} | |||
== Additional Info == | == Additional Info == | ||
*[https://en.wikipedia.org/wiki/Neuroleptic_malignant_syndrome Neuroleptic malignant syndrome] | |||
** MNS is an adverse reaction to neuroleptic or antipsychotic drugs characterized by F E V E R: | |||
** F =Temp>38 | |||
** E=Encephalopathy | |||
** V=Vitals signs are unstable | |||
** E =Elevated CPKs | |||
** R=Rigidity muscles | |||
Drugs such as Haldol, Chlorpromazine, Metoclopramides, Lithium,and antiparkinson drugs Levodopa can cause MNS. | |||
== Alternate ICD10s to consider coding instead or in addition == | |||
== Candidate [[Combined ICD10 codes]] == | |||
*[[Myoglobinuria]] | |||
*[[Iatrogenic, complication of medical or surgical care NOS]] | |||
== Related CCI Codes == | |||
{{Data Integrity Check List}} | |||
== Related Articles == | |||
{{Related Articles}} | |||
{{ICD10 footer}} | |||
{{ | {{EndPlaceHolder}} | ||